Here are five things to know:
1. The company will introduce GELSYN-3, CellXtract and SIGNAFUSE Bioactive Bonegraft Putty at the meeting.
2. The GELSYN-3 is a three-injection, hyaluronic acid-based product for pain relief from knee osteoarthritis.
3. CellXtract is a novel cell and bone marrow extraction tool.
4. SIGNAFUSE Bioactive Bonegraft Putty is a graft comprised of a bi-phasic mineral composite combined with a patented bioactive glass and resorbable polymer carrier.
5. Bioventus is an orthobiologics company with two product portfolios — Bioventus Active Healing Therapies and Bioventus Surgical.
More articles on devices:
Medical Compression Systems unveils ActiveCare platform at AAOS meeting — 4 takeaways
Medacta showcases latest surgical innovations at AAOS meeting — 5 takeaways
EOS imaging’s spineEOS receives CE Mark: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
